Business
Remdesivir study by World Health Organisation casts doubt, disputed by Gilead Sciences Inc – 7NEWS.com.au
The antiviral medication was one of the drugs used to treat US President Donald Trump after his COVID-19 diagnosis.
Gilead Sciences Inc has questioned the findings of a World Health Organisation (WHO) study that concluded its COVID-19 drug remdesivir does not help patients who have been admitted to hospital.
The American company told Reuters the data appeared inconsistent, the findings were premature and that other studies had validated the drugs benefits.
In a blow to one of the few drugs being used to treat people with COVID-19, the WHO said on Thursday its Solidarity trial had concluded that remdesivir a…
-
General22 hours agoWondering about winter | The Spectator Australia
-
Noosa News21 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General20 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business23 hours agoWiseTech shares lift off amid agreement with founder Richard White